Lemonade, Inc. (NYSE:LMND – Get Free Report) Director Michael A. Eisenberg sold 12,000 shares of the business’s stock in a transaction dated Friday, December 13th. The stock was sold at an average price of $40.15, for a total transaction of $481,800.00. Following the transaction, the director now owns 94,670 shares in the company, valued at approximately $3,801,000.50. This trade represents a 11.25 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Lemonade Stock Performance
Shares of LMND opened at $39.18 on Thursday. Lemonade, Inc. has a fifty-two week low of $14.03 and a fifty-two week high of $53.85. The business has a 50-day moving average of $33.20 and a 200 day moving average of $23.09. The firm has a market cap of $2.80 billion, a P/E ratio of -12.89 and a beta of 2.09.
Lemonade (NYSE:LMND – Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported ($0.95) earnings per share for the quarter, topping the consensus estimate of ($1.02) by $0.07. The firm had revenue of $136.60 million during the quarter, compared to the consensus estimate of $129.10 million. Lemonade had a negative net margin of 43.51% and a negative return on equity of 32.85%. The company’s revenue was up 19.3% on a year-over-year basis. During the same quarter last year, the company earned ($0.88) earnings per share. As a group, research analysts predict that Lemonade, Inc. will post -3.04 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Lemonade
Analyst Upgrades and Downgrades
A number of equities analysts have recently weighed in on LMND shares. BMO Capital Markets boosted their target price on Lemonade from $13.00 to $15.00 and gave the stock an “underperform” rating in a research note on Thursday, November 21st. Morgan Stanley upgraded Lemonade from an “underweight” rating to an “equal weight” rating and upped their price objective for the company from $23.00 to $42.00 in a research note on Wednesday, November 20th. JMP Securities lifted their target price on Lemonade from $40.00 to $60.00 and gave the stock a “market outperform” rating in a research note on Friday, November 22nd. Piper Sandler increased their price target on shares of Lemonade from $25.00 to $44.00 and gave the company a “neutral” rating in a research report on Thursday, November 21st. Finally, Jefferies Financial Group decreased their price objective on shares of Lemonade from $15.00 to $14.00 and set an “underperform” rating for the company in a report on Wednesday, October 9th. Three equities research analysts have rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $30.43.
View Our Latest Analysis on Lemonade
About Lemonade
Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.
Recommended Stories
- Five stocks we like better than Lemonade
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Want to Profit on the Downtrend? Downtrends, Explained.
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Lemonade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lemonade and related companies with MarketBeat.com's FREE daily email newsletter.